0000950170-24-008020.txt : 20240126
0000950170-24-008020.hdr.sgml : 20240126
20240126171005
ACCESSION NUMBER: 0000950170-24-008020
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240124
FILED AS OF DATE: 20240126
DATE AS OF CHANGE: 20240126
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WILSON TROY EDWARD
CENTRAL INDEX KEY: 0001589597
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37620
FILM NUMBER: 24568855
MAIL ADDRESS:
STREET 1: C/O KURA ONCOLOGY, INC.
STREET 2: 12730 HIGH BLUFF DRIVE, SUITE 400
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kura Oncology, Inc.
CENTRAL INDEX KEY: 0001422143
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 611547851
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12730 HIGH BLUFF DRIVE, SUITE 400
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 500-8800
MAIL ADDRESS:
STREET 1: 12730 HIGH BLUFF DRIVE, SUITE 400
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: ZETA ACQUISITION CORP III
DATE OF NAME CHANGE: 20071227
4
1
ownership.xml
4
X0508
4
2024-01-24
0001422143
Kura Oncology, Inc.
KURA
0001589597
WILSON TROY EDWARD
C/O KURA ONCOLOGY, INC.
12730 HIGH BLUFF DRIVE, SUITE 400
SAN DIEGO
CA
92130
true
true
false
false
President and CEO
false
Common Stock
2024-01-24
4
M
false
6945
4.80
A
7504
D
Common Stock
2024-01-24
4
S
false
6945
20.23
D
559
D
Common Stock
2024-01-24
4
M
false
84107
6.15
A
84666
D
Common Stock
2024-01-24
4
S
false
84107
20.23
D
559
D
Common Stock
300000
I
by Lorax Charitable Remainder Unitrust
Common Stock
279194
I
by One Fish Two Fish Revocable Trust
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 20, 2022.
Teresa Bair, Attorney-in-fact for Troy E. Wilson
2024-01-26